Results 21 to 30 of about 2,473 (178)

The mPEG-PCL Copolymer for Selective Fermentation of Staphylococcus lugdunensis Against Candida parapsilosis in the Human Microbiome. [PDF]

open access: yes, 2016
Many human skin diseases, such as seborrheic dermatitis, potentially occur due to the over-growth of fungi. It remains a challenge to develop fungicides with a lower risk of generating resistant fungi and non-specifically killing commensal microbes.
Barshop, Bruce A   +15 more
core   +1 more source

Onychomycosis unresponsive to antifungals: Etiology and treatment with a new direct technique

open access: yesIndian Journal of Dermatology, 2019
Aims and Objectives: The aim of this study was to identify the fungal agents causing onychomycosis that were unresponsive to antifungal treatment and to treat these cases by placing under-nail cushions with a mild keratolytic to clear the fungus-invaded ...
Fatma Gülru Erdogan   +2 more
doaj   +1 more source

Bilateral Tinea Nigra Plantaris with Good Response to Isoconazole Cream: A Case Report

open access: yesCase Reports in Dermatology, 2015
Tinea nigra is a superficial fungal infection caused by Hortaea werneckii. It typically affects young individuals as an asymptomatic unilateral macule, from light brown to black on the palms and soles, mainly in tropical and subtropical regions. In 1997,
Eduardo Mastrangelo Marinho Falcão   +4 more
doaj   +1 more source

A unique case of a digital tourniquet in ichthyosis vulgaris [PDF]

open access: yes, 2020
We report a unique case of a digital tourniquet in a patient with ichthyosis vulgaris. We have identified no previous case reports documenting the occurrence of a digital tourniquet in patients caused by this condition.
McClymont, L. F., Ng, M.
core   +2 more sources

Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. [PDF]

open access: yes, 2013
Advances in nanotechnology have demonstrated potential application of nanoparticles (NPs) for effective and targeted drug delivery. Here we investigated the antimicrobial and immunological properties and the feasibility of using NPs to deliver ...
Blecher-Paz, Karin   +10 more
core   +1 more source

Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris-A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disorder that can severely impact the quality of life in patients, particularly when presenting in chronic or refractory form. Emerging evidence suggests that JAK inhibitors may offer a potential treatment option.
Taremi M, Mozafari N.
europepmc   +2 more sources

Medicinal Plants for the Treatment of Acne Vulgaris: A Review of Recent Evidences [PDF]

open access: yes, 2015
Context: Acne vulgaris affects about 85% of teenagers and may continue to adulthood. There are about two million visits to physicians per year for teenagers and the direct cost of acne treatment in the US exceeds $1 billion per year. Evidence Acquisition:
Bahmani, Mahmoud.   +5 more
core   +2 more sources

Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis [PDF]

open access: yes, 2016
Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the outcome of therapy and of the development of comorbidities.
Cavaliere, Arturo   +2 more
core   +2 more sources

Surface Active Agents: Chemical Types and Applications [PDF]

open access: yes, 1945
Newsletter providing "a lighter, human interest side of the news" from the Boston University Medical ...
Boston University Medical Center   +2 more
core   +1 more source

Post endodontic Aspergillosis in an immunocompetent individual [PDF]

open access: yes, 2015
Non-invasive aspergillosis in immunocompetent individuals subsequent to post endodontic treatment can involve the maxillary antrum. An early and accurate diagnosis will aid in prompt and effective treatment. A 35 year old female patient reported with a
Gupta, Shalini   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy